Can a screening programme for diabetes be applied to another population?

PubWeight™: 0.83‹?›

🔗 View Article (PMID 16108854)

Published in Diabet Med on September 01, 2005

Authors

C Glümer1, K Borch-Johnsen, S Colagiuri

Author Affiliations

1: Steno Diabetes Center. Gentofte, Denmark. ChGl@Steno.dk

Associated clinical trials:

Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease | NCT00289237

Articles by these authors

Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia (1989) 5.68

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med (2009) 4.89

The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord (2000) 3.83

Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia (2001) 3.76

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1985) 3.75

The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia (2008) 3.59

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57

Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia (2004) 3.26

The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia (2007) 3.07

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05

Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology (1996) 2.91

Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 2.88

Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 2.81

The extent of undiagnosed gestational diabetes mellitus in New South Wales. Med J Aust (1997) 2.70

Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J Nutr (2002) 2.47

Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia (2003) 2.37

The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33

Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ (1994) 2.31

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28

Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia (1998) 2.25

Physiological validation of the concept of glycemic load in lean young adults. J Nutr (2003) 2.20

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med (2010) 2.07

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ (1997) 2.02

Diabetes and accident insurance. A 3-year follow-up of 7,599 insured diabetic individuals. Diabetes Care (1997) 2.02

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00

Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med (2006) 1.86

Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract (2009) 1.83

Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. J Epidemiol Community Health (1998) 1.80

Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia (2008) 1.70

Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract (2005) 1.66

The quality of self-monitoring of blood glucose. Diabet Med (1990) 1.62

Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia (1995) 1.57

International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet Med (2008) 1.55

Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation (2001) 1.55

The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study. Diabet Med (2005) 1.53

Mortality in women and men in relation to smoking. Int J Epidemiol (1998) 1.52

Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51

Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia (2009) 1.48

Diabetes Control and Complications Trial. Position statement of the Australian Diabetes Society. Med J Aust (1994) 1.47

Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension (2000) 1.47

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia (2004) 1.46

Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens (1997) 1.45

Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45

Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia (1986) 1.44

The use and perceived value of diabetes clinical management guidelines in general practice. Aust Fam Physician (2000) 1.44

The FOXC2 -512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects. Diabetologia (2003) 1.43

Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care (1999) 1.42

Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Lond) (1995) 1.42

Cumulative glycaemia as measured by lens fluorometry: association with retinopathy in type 2 diabetes. Diabetologia (2010) 1.41

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia (1987) 1.41

[Alcoholic ketoacidosis]. Ugeskr Laeger (1995) 1.40

There really is an epidemic of type 2 diabetes. Diabetologia (2005) 1.40

[The association of alcohol and mortality. Significance of gender,age, weight and smoking]. Ugeskr Laeger (1994) 1.39

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia (2010) 1.36

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia (2008) 1.35

The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabet Med (1987) 1.34

Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest (2001) 1.33

A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk (2001) 1.30

Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy. Diabetologia (2004) 1.29

The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study. Eur J Clin Nutr (2006) 1.29

Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people. Diabetologia (2010) 1.27

Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia (2000) 1.26

Comparability of venous and capillary glucose measurements in blood. Diabet Med (2003) 1.26

Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia (2002) 1.23

Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia (2004) 1.22

Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia (2006) 1.20

HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia (2010) 1.20

Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes (1987) 1.20

Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med (2001) 1.18

Low-glycemic index foods improve long-term glycemic control in NIDDM. Diabetes Care (1991) 1.17

The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome. Diabetologia (2005) 1.17

A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics (1985) 1.17

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia (2005) 1.16

Inuit health in Greenland: a population survey of life style and disease in Greenland and among Inuit living in Denmark. Int J Circumpolar Health (2003) 1.16

The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med (2008) 1.16

Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia (2010) 1.16

Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Eur Psychiatry (2011) 1.15

Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest (2002) 1.15

Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology (1998) 1.15

Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): relationship to metabolic risk factors. Int J Obes Relat Metab Disord (2003) 1.15

Relative validity of a food frequency questionnaire used in the Inter99 study. Eur J Clin Nutr (2007) 1.14

Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia (2007) 1.13

Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction. Diabetologia (2009) 1.11

The rise and fall of the metabolic syndrome. Diabetologia (2010) 1.11

A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complications (2001) 1.10

Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway. Clin Obes (2013) 1.09

HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08

Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabet Med (1994) 1.08

Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ (1996) 1.07

The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia (2006) 1.07

Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens (1998) 1.07

Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians. Diabetologia (2001) 1.06

Improved survival in patients with diabetic nephropathy. Diabetologia (1989) 1.06

Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia (2007) 1.04

Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study. Diabet Med (2010) 1.04

Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark. Diabetologia (2006) 1.03

Diabetes in Greenland and its relationship with urbanization. Diabet Med (2012) 1.03

Screening for type 2 diabetes. Lessons from the ADDITION-Europe study. Diabet Med (2011) 1.02